Debevoise Advises CPP Investments as Lead Investor in insitro’s $400 Million Series C Financing

18 March 2021

Debevoise & Plimpton LLP is advising Canada Pension Plan Investment Board (CPP Investments) as the lead investor in insitro’s $400 million Series C financing. For more information, please see the company’s press release.

CPP Investments is a professional investment management organization that invests around the world in the best interests of the more than 20 million contributors and beneficiaries of the Canada Pension Plan. insitro is a machine learning-driven drug discovery and development company.

The Debevoise team is led by M&A partner Kevin Schmidt and includes counsel David Iozzi and associates Kim Le, Melissa Runsten and Milan Udawatta, benefits associate Matthew Trudeau, tax associate Gregory Arutiunov, capital markets associate Benjamin Pedersen, data strategy and security partner Luke Dembosky, intellectual property associate Paisley Piasecki, antitrust counsel Kyra Bromley, FDA regulatory partner Paul Rubin and regulatory partner Andrew Levine and associate Sarah Wolf.